Early research (Phase 1)Study completedNCT04834778
What this trial is testing
HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Who this might be right for
Renal Cell CarcinomaGastric CancerMetastatic Breast Cancer+2 more
HiberCell, Inc. 23
Showing 20 of 0 results